ObvioHealth and 1nHealth Launch Initiative to Rescue Clinical Trials Struggling to Transition to Decentralization
Tuesday, March 8, 2022
Pandemic-driven adoption of hybrid and fully virtual clinical trials has left many sponsors in need of support in patient recruitment and protocol optimization
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- ObvioHealth and 1nHealth announce today a joint initiative to smooth the transition to hybrid and decentralized clinical research. The initiative focuses on supporting clinical trials that may be struggling due to suboptimal protocol design, imprecise recruitment strategies, maladapted technology options or ailing site teams. According to clinicaltrials.gov, there are about 1,600 suspended trials at present.
1nHealth conducts clinical trial recruitment using a unique combination of digital targeting and evidence-based creative that enabled it to deliver 100 percent of their 2021 DCT enrollment projects on time and on budget, a result that is virtually unheard of in the industry.
ObvioHealth is a leading global Virtual Research Organization (VRO) delivering end-to-end decentralized clinical trial solutions through its platform, smartphone app and seamless device integrations. The company boasts average study retention rates of 89 percent.
"It's wonderful to see the industry rapidly adopting hybrid and virtual models, but this has sponsors confronting new recruitment challenges," said Dan Brenner, Founder and CEO of 1nHealth. "We frequently hear from sponsors who can't meet enrollment numbers and are increasingly brought on board to help get trials back on track."
Both companies have leveraged their DCT and hybrid expertise to rescue trials that are failing to meet milestones. They recently collaborated on a women's health study that considerably boosted enrollment and study completion rates, while reducing recruitment costs 10-fold.
"So many sponsors are grappling with cost overages and delayed timelines at the moment," said Ivan Jarry, CEO of ObvioHealth. "As a pioneer in decentralized clinical trials, we've learned many lessons about how to optimally digitize studies through better trial design and more efficient patient-centric execution. We are eager to apply those learnings to help sponsors salvage their trials to generate the evidence they need."
For more information on this joint initiative, click here.
About ObvioHealth
ObvioHealth is an end-to-end?Virtual Research Organization (VRO) that delivers better data to sponsors and an easier clinical trial experience for participants. The company developed and launched one of the first patient-centric apps downloadable on smartphones, enabling?people to participate in clinical trials from the comfort of their homes. In the 5 years since launch, the company has been awarded?46 studies from 28 blue chip clients, implemented in 26?countries, across 18 different therapeutic areas. For more information, visit www.obviohealth.com.
About 1nHealth
1nHealth fills studies faster by using novel methodologies to deliver high-performing ads across all digital channels. Based in Orlando, Florida, 1nHealth uses AI to help find patients who are simply being missed by other recruitment vendors. 1nHealth works with top CROs, Pharma companies and most of the leading DCT providers, as well as across 40+ TAs, delivering full enrollment for site-based, hybrid, and fully decentralized studies. Visit www.1nhealth.com to learn more.
View original content to download multimedia:https://www.prnewswire.com/news-releases/obviohealth-and-1nhealth-launch-initiative-to-rescue-clinical-trials-struggling-to-transition-to-decentralization-301490594.html
SOURCE ObvioHealth
|
|
|
|
|
 |
Asetek - Mandatory Notification of Trade | Jan 22, 2026
|
|
Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
|
|
BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
|
|
Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
|
|
Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
|
|
California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
|
|
AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
|
|
Gemmy Alerts Customers: Fake Websites Target Holiday Decorators | Jan 22, 2026
|
|
Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
|
|
AMPLIFY Named Finalist in Three Categories at the 2026 Golden Gavel Awards | Jan 22, 2026
|
|
|
